Skip to main content
Retour
Watch Compare

LIXTE BIOTECHNOLOGY HOLDINGS, INC.

Qualité des données : 83%
LIXT
NASDAQ Manufacturing Chemicals
2,91 €
▼ 0,05 € (-1,52%)
6 months return
—
Momentum
Neutral
ROE
-218,51%

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-218,51%
En dessous de la moyenne du secteur (-54,68%)
ROIC-145,05%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio10,42
Interest Coverage-557,72

Valorisation

PE (TTM)
-5,60
En dessous de la moyenne du secteur (-1,50)
P/B Ratio6,93
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Negative free cash flow of -3,07 M

Price History

Tendances Financières

Objectif de Cours des Analystes

Aucune couverture d'analyste disponible

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: -218,51% · Net Margin: N/A
Revenue (TTM) N/A Net Income (TTM) -6,08 M
ROE -218,51% ROA -183,58%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -3,07 M
ROIC -145,05% FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: 10,42
Debt / Equity N/A Current Ratio 10,42
Interest Coverage -557,72 Asset Turnover N/A
Working Capital 4,91 M Tangible Book Value 4,91 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -5,60 · EV/EBITDA: N/A
P/E Ratio -5,60 Forward P/E N/A
P/B Ratio 6,93 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -9,02%
Market Cap 34,04 M Enterprise Value 34,04 M

Per Share

EPS: -1,26 · FCF/Share: -0,26
EPS (Diluted TTM) -1,26 Revenue / Share N/A
FCF / Share -0,26 OCF / Share -0,26
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 50,52% · CapEx/Rev: N/A
CapEx / Revenue N/A FCF Conversion 50,52%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -6,08 M -3,59 M -5,09 M -6,31 M -6,73 M
EPS (Diluted) -1,26 -1,59 -2,66 — —
Gross Profit — — — — —
Operating Income -5,11 M -3,57 M -5,09 M -6,31 M -6,72 M
EBITDA — — — — —
R&D Expenses 254 919,0 726 232,0 898 100,0 1,35 M 1,74 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 9 158,0 16 821,0 16 233,0 8 875,0 7 414,0
Income Tax 1 600,0 — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 12,73 M 1,15 M 4,31 M 5,56 M 5,09 M
Total Liabilities 1,77 M — — — —
Shareholders' Equity 9,66 M 827 219,0 3,99 M 5,17 M 4,79 M
Total Debt — — — — —
Cash & Equivalents — — 4,20 M 5,35 M 4,82 M
Current Assets 5,18 M — 4,31 M 5,56 M 5,09 M
Current Liabilities 1,33 M 318 284,0 313 858,0 394 786,0 302 926,0

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1605 pairs)
Métrique Action Médiane du Secteur
P/E -5,6 -1,5
P/B 6,9 1,6
ROE % -218,5 -54,7
Net Margin % — -41,5
Rev Growth 5Y % — 1,7
D/E — 0,3